Past Issues

• 8

  The Role Of Patient Reported Outcomes To Support Reimbursement And Market Access In Major European Countries And The Us

  Lothar Tremmel, Vice President, QCSR at CSL Behring

• 19

  Could A Syndromic Diagnosis Overcome Challenges Faced By Antimicrobial Stewardship Programs During The Covid-19 Pandemic?

  Sonia N. Rao, PharmD, BCIDP and Davide Manissero, MD, MRCPCH, MSc, DTM&H, QIAGEN

• 24

  The Role Of Data In Delivering Best Patient-Care

  Stewart Fossceco, Vice President, Quality Analytics, Invitae

• 26

  Accelerating Drug Development Of Novel Targeted Therapies Through Histology-Agnostic Oncology Clinical Trials

  Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker at Zai Lab

• 28

  Challenges And Opportunities For AI In Drug Discovery

  Robert J Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Research Institute, Inc. and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring Research Institute, Inc.

• 30

  Growing demand for More Specialized Services Specialized Services: A New Paradigm in Therapeutics

  Brian Fry, Director, Global Cell Therapy, Charles River Laboratories